PPA
LMAT icon

Parametric Portfolio Associates’s LeMaitre Vascular LMAT Stock Holding History

Parametric Portfolio Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.42M Buy
116,740
+3,211
+3% +$144K ﹤0.01% 1793
2021
Q4 		$5.7M Sell
113,529
-15,180
-12% -$785K ﹤0.01% 1773
2021
Q3 		$6.83M Buy
128,709
+19,276
+18% +$1.09M ﹤0.01% 1621
2021
Q2 		$6.68M Buy
109,433
+36,618
+50% +$1.95M ﹤0.01% 1658
2021
Q1 		$3.55M Buy
72,815
+4,143
+6% +$194K ﹤0.01% 2402
2020
Q4 		$2.78M Buy
68,672
+14,690
+27% +$525K ﹤0.01% 2452
2020
Q3 		$1.76M Buy
53,982
+12,637
+31% +$379K ﹤0.01% 2588
2020
Q2 		$1.09M Sell
41,345
-989
-2% -$25.9K ﹤0.01% 2876
2020
Q1 		$1.05M Sell
42,334
-4,331
-9% -$134K ﹤0.01% 2767
2019
Q4 		$1.68M Buy
46,665
+8,379
+22% +$289K ﹤0.01% 2797
2019
Q3 		$1.31M Buy
38,286
+9,278
+32% +$296K ﹤0.01% 2887
2019
Q2 		$812K Sell
29,008
-1,214
-4% -$33.7K ﹤0.01% 3152
2019
Q1 		$937K Buy
30,222
+7,669
+34% +$205K ﹤0.01% 3063
2018
Q4 		$533K Sell
22,553
-8,194
-27% -$224K ﹤0.01% 3279
2018
Q3 		$1.19M Buy
30,747
+2,509
+9% +$90.4K ﹤0.01% 2992
2018
Q2 		$945K Buy
28,238
+1,740
+7% +$61.9K ﹤0.01% 3089
2018
Q1 		$960K Buy
26,498
+4,469
+20% +$155K ﹤0.01% 3043
2017
Q4 		$701K Sell
22,029
-4,714
-18% -$161K ﹤0.01% 3174
2017
Q3 		$1M Buy
26,743
+501
+2% +$17.1K ﹤0.01% 3046
2017
Q2 		$819K Sell
26,242
-15,637
-37% -$452K ﹤0.01% 3091
2017
Q1 		$1.03M Sell
41,879
-33,724
-45% -$792K ﹤0.01% 2840
2016
Q4 		$1.92M Buy
75,603
+14,507
+24% +$322K ﹤0.01% 2389
2016
Q3 		$1.21M Buy
61,096
+39,226
+179% +$685K ﹤0.01% 2687
2016
Q2 		$312K Sell
21,870
-15,987
-42% -$244K ﹤0.01% 3433
2016
Q1 		$588K Buy
37,857
+23,766
+169% +$341K ﹤0.01% 3245
2015
Q4 		$243K Buy
+14,091
New +$204K ﹤0.01% 3647

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Parametric Portfolio Associates's LMAT Position: Q1 2022 in Review

Parametric Portfolio Associates increased its LeMaitre Vascular (LMAT) stake by 2.8% in Q1 2022, buying an estimated $144K and bringing the position to 116,740 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Parametric Portfolio Associates first reported a position in LMAT in Q4 2015 and has held it in 26 quarters since. The position peaked at $6.83M in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Parametric Portfolio Associates held 116,740 shares of LeMaitre Vascular worth $5.42M as of Q1 2022.
  • Parametric Portfolio Associates bought 3,211 LeMaitre Vascular shares in Q1 2022, an estimated $144K.
  • LeMaitre Vascular made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1793 holding.
  • Parametric Portfolio Associates first reported a position in LeMaitre Vascular in Q4 2015 and has held it in 26 quarters since.
  • Parametric Portfolio Associates's LeMaitre Vascular position peaked at $6.83M in Q3 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.